Why You Should Attend
This two day conference will enable attendees to streamline risk mitigation and improve drug safety by leveraging tools and technologies and interpreting developments in regulatory compliance. The 7thinstallment of Pharmacovigilance, Drug Safety & Risk Management will focus on improving PV strategies to enable predictive drug safety in order to increase patient safety, and decrease drug risk potential.
Develop more proficient and profound pharmacovigilance strategies to utilize throughout product lifecycle. Streamline drug safety and regulatory approval process and increase patient voluntary reporting.
Key Topics
-
Identify trends in pharmacovigilance to establish predictive drug safety methods
-
Examine existing compliance framework to assess potential impacts of forthcoming regulations affecting
-
Incorporate pharmacovigilance throughout product lifecycle, from clinical development to patient care in order to improve drug safety
-
Leverage tools and technology to enhance pharmacovigilance strategy integration
-
Interpret & utilize real world evidence for optimized signal management
Previous Attendees Include
Baxter Healthcare Corporation, Biogen Idec, Eli Lilly, Gilead
Sciences, Halozyme Therapeutics, Ipsen Biopharmaceuticals,
Merck, Sanofi, Shire Human Genetic Therapies, Takeda
Pharmaceuticals USA, Novartis Pharmaceuticals Corporation,
Cubist Pharmaceuticals, Inc., EMD Serono, Inc., Pfizer, Inc.,
Johnson and Johnson, Amgen, and many more!
Why Choose marcus evans?
marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.
Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.

Comments
Log in or sign up to join the conversation.